| Fibroblasts mobilize tumor cell glycogen to promote proliferation and metastasis M Curtis, HA Kenny, B Ashcroft, A Mukherjee, A Johnson, Y Zhang, ... Cell metabolism 29 (1), 141-155. e9, 2019 | 236 | 2019 |
| Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy LE Kenny HA, Lal-Nag M, White EA, Shen M2, Chiang CY1, Mitra AK, Zhang Y ... Nature communication, 2015 | 185 | 2015 |
| Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models E Lengyel, LM Litchfield, AK Mitra, KM Nieman, A Mukherjee, Y Zhang, ... American journal of obstetrics and gynecology 212 (4), 479. e1-479. e10, 2015 | 143 | 2015 |
| Facile synthesis of multivalent folate-block copolymer conjugates via aqueous RAFT polymerization: targeted delivery of siRNA and subsequent gene suppression AW York, Y Zhang, AC Holley, Y Guo, F Huang, CL McCormick Biomacromolecules 10 (4), 936-943, 2009 | 137 | 2009 |
| Human organoids share structural and genetic features with primary pancreatic adenocarcinoma tumors I Romero-Calvo, CR Weber, M Ray, M Brown, K Kirby, RK Nandi, ... Molecular Cancer Research 17 (1), 70-83, 2019 | 100 | 2019 |
| Reversal of chemoresistance in ovarian cancer by co-delivery of a P-glycoprotein inhibitor and paclitaxel in a liposomal platform Y Zhang, SK Sriraman, HA Kenny, E Luther, V Torchilin, E Lengyel Molecular Cancer Therapeutics, 2016 | 75 | 2016 |
| Tailored Design of Au Nanoparticle-siRNA Carriers Utilizing Reversible Addition− Fragmentation Chain Transfer Polymers S Kirkland-York, Y Zhang, AE Smith, AW York, F Huang, CL McCormick Biomacromolecules 11 (4), 1052-1059, 2010 | 72 | 2010 |
| A pan-cancer organoid platform for precision medicine BM Larsen, M Kannan, LF Langer, BD Leibowitz, A Bentaieb, A Cancino, ... Cell reports 36 (4), 2021 | 63 | 2021 |
| Synthesis of biotin–AMP conjugate for 5′ biotin labeling of RNA through one-step in vitro transcription F Huang, J He, Y Zhang, Y Guo Nature protocols 3 (12), 1848-1861, 2008 | 61 | 2008 |
| Urokinase plasminogen activator system–targeted delivery of nanobins as a novel ovarian cancer therapy Y Zhang, HA Kenny, EP Swindell, AK Mitra, PL Hankins, RW Ahn, K Gwin, ... Molecular cancer therapeutics 12 (12), 2628-2639, 2013 | 39 | 2013 |
| Preclinical evaluation of artesunate as an antineoplastic agent in ovarian cancer treatment A McDowell Jr, KS Hill, JR McCorkle, J Gorski, Y Zhang, AA Salahudeen, ... Diagnostics 11 (3), 395, 2021 | 16 | 2021 |
| Prolactin Receptor–Mediated Internalization of Imaging Agents Detects Epithelial Ovarian Cancer with Enhanced Sensitivity and Specificity KM Sundaram, Y Zhang, AK Mitra, JLK Kouadio, K Gwin, AA Kossiakoff, ... Cancer research 77 (7), 1684-1696, 2017 | 14 | 2017 |
| Folate receptor-targeted delivery of small interfering RNA to cancer cells Y Zhang The University of Southern Mississippi, 2010 | 4 | 2010 |
| 脱落酸对水稻种子萌发及相关基因表达的影响 张宜麟， 赵帆， 赵洁 武汉植物学研究 23 (3), 203-210, 2005 | 3 | 2005 |
| A platform of CDK4/6 inhibitor-resistant patient-derived breast cancer organoids illuminates mechanisms of resistance and therapeutic vulnerabilities ABH Hanker, S Chatterjee, Y Wang, D Ye, DR Sudhan, BM Larsen, ... AACR; Cancer Res 82 (4 Suppl), Abstract nr PD2-01, 2022 | 1 | 2022 |
| Targeted delivery of doxorubicin loaded nanobins to ovarian cancer cells through the urokinase plasminogen activator system Y Zhang, EP Swindell, PL Hankins, HA Kenny, TV O'Halloran, AP Mazar, ... 10th Biennial Ovarian Cancer Research Symposium 21 (16 Supplement), 1440, 2015 | 1* | 2015 |
| Systems and methods for predicting therapeutic sensitivity A Salahudeen, BM Larsen, MM Stein, LA Karginov, M Kannan, AA Khan, ... US Patent App. 17/771,401, 2022 | | 2022 |
| Large scale organoid analysis BM Larsen, MM Stein, LA Karginov, A Salahudeen, M Kannan, AA Khan, ... US Patent App. 17/857,901, 2022 | | 2022 |
| Integrated machine-learning framework to estimate homologous recombination deficiency RT Aarti Venkat, Jerod Parsons,Joshua S K Bell,Catherine Igartua,Yilin Zhang ... US Patent US10975445B2, 2021 | | 2021 |
| Abstract POSTER-THER-1440: Targeted delivery of doxorubicin loaded nanobins to ovarian cancer cells through the urokinase plasminogen activator system Y Zhang, EP Swindell, PL Hankins, HA Kenny, TV O'Halloran, AP Mazar, ... Clinical Cancer Research 21 (16_Supplement), POSTER-THER-1440-POSTER-THER-1440, 2015 | | 2015 |
Ernst LengyelProfessor of Gynecologic Oncology, University of ChicagoBestätigte E-Mail-Adresse bei uchicago.edu
